Unresolved issues in prophylaxis

Haemophilia. 2002 Nov;8(6):817-21. doi: 10.1046/j.1365-2516.2002.00685.x.
No abstract available

Publication types

  • Congress
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Drug Administration Schedule
  • Factor IX / administration & dosage
  • Factor VIII / administration & dosage
  • Health Care Costs
  • Hemophilia A / complications
  • Hemophilia A / drug therapy*
  • Hemophilia B / complications
  • Hemophilia B / drug therapy*
  • Humans
  • Infant
  • Joint Diseases / diagnosis
  • Joint Diseases / etiology
  • Joint Diseases / prevention & control*
  • Male
  • Quality of Life

Substances

  • Factor VIII
  • Factor IX